Related Experiment Videos

Radiation-induced phosphorylation of Chk1 at S345 is associated with p53-dependent cell cycle arrest pathways

Hui Tian1, Alexander T Faje, Siu Lan Lee

  • 1Department of Radiation Medicine, Lombardi Cancer Center, Georgetown University Medical Center, 3970 Reservoir Road, N.W., Washington, DC 20007-2197, USA.

Neoplasia (New York, N.Y.)
|March 16, 2002
PubMed

Insights

Understanding how Chk1 and p53 coordinate cell cycle arrest after DNA damage is key for cancer therapy. This study reveals Chk1 phosphorylation at S345 links it to p53, coordinating DNA damage responses.

Area of Science:

  • Molecular Biology
  • Cell Biology
  • Cancer Research

Background:

  • DNA damage-inducible cell cycle checkpoints protect cells from ionizing radiation.
  • Chk1 and p53 are major regulators of G2 arrest, but their interaction during radiation-induced G2 arrest is unclear.
  • Understanding these mechanisms may reveal new cancer therapy targets.

Purpose of the Study:

  • To determine the role of Chk1 in p53-dependent G2 arrest.
  • To investigate the interaction and coordination of Chk1 and p53 during radiation-induced G2 arrest.
  • To explore the impact of UCN-01 on these processes.

Main Methods:

  • Used p53 proficient cells to examine G2 arrest protein expression.
  • Inhibited G2 arrest using the staurosporine analog UCN-01.
  • Assessed protein phosphorylation and binding interactions using Western blotting and co-immunoprecipitation.

Main Results:

  • UCN-01 inhibited both G1 and G2 arrest in irradiated cells, suppressing p21 and 14-3-3 sigma expression.
  • p53 induction and phosphorylation of p53 (S20) and Cdc25C (S216) were normal despite UCN-01 treatment.
  • Radiation-induced Chk1 phosphorylation at S345 correlated with binding to p53, p21, and 14-3-3 sigma; UCN-01 inhibited this phosphorylation.

Conclusions:

  • DNA damage-induced Chk1 phosphorylation at S345 links Chk1 to p53 downstream responses.
  • This phosphorylation and subsequent p53 binding may coordinate DNA damage responses and cell cycle arrest.
  • Findings suggest a potential molecular target for cancer therapy by modulating Chk1-p53 interactions.

Related Concept Videos